Quince Therapeutics, Inc. (QNCX)
1.15
-0.03
(-2.54%)
USD |
NASDAQ |
May 15, 16:00
1.16
+0.01
(+0.87%)
After-Hours: 20:00
Quince Therapeutics Shareholders Equity (Quarterly) : 15.67M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 1.025B |
| BioXcel Therapeutics, Inc. | -95.46M |
| Gossamer Bio, Inc. | -122.76M |
| Ernexa Therapeutics, Inc. | 6.859M |
| Acurx Pharmaceuticals, Inc. | 7.013M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.62M |
| Total Liabilities (Quarterly) | 10.95M |
| Debt to Equity Ratio | 0.0259 |
| Current Ratio | 2.917 |
| Net Debt Paydown Yield | 50.99% |